Shaanxi Kanghui Pharmaceutical (603139.SH) plans to change its stock abbreviation to "Kanghui shares".
Kanghui Pharmaceutical (603139.SH) announced that, according to the company's long-term development plan, the company plans to change its stock abbreviation from "..."
Shaanxi Kanghui Pharmaceutical (603139.SH) has announced that, in accordance with the company's long-term development plan, it plans to change its stock abbreviation from "Shaanxi Kanghui Pharmaceutical" to "Kanghui Pharmaceuticals". The new stock abbreviation is concise and clear, retaining the core brand identity of "Kanghui" while also adding the word "Pharmaceuticals", which will help the market better understand the company's development positioning and enable investors to accurately grasp the company's core values and development direction.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
